色素沉着症治疗市场策略、顶级参与者、增长机会、2030 年分析和预测

  • Report Code : TIPRE00029977
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 158
Buy Now

Hyperpigmentation Disorder Treatment Market Forecast to 2030

Buy Now

 

色素沉着症治疗市场预测可以帮助该市场的利益相关者概述其增长战略。预计该市场将从 2022 年的 66.8 亿美元增长到 2030 年的 117.8 亿美元;预计 2022-2030 年的复合年增长率为 7.4%。

简化和微创手术、广泛的应用范围以及技术进步带来的舒适度、效率和效果的改善等因素推动了 色素沉着症治疗市场的发展。然而,潜在的副作用和监管挑战阻碍了市场的增长。基于 path-3 技术的新产品的日益普及预计将在未来几年为色素沉着症治疗市场带来新的趋势。

 

增长动力:

 

越来越多的色素沉着障碍宣传计划推动市场增长

开展活动以提高人们对紫外线引起的皮肤色素沉着的认识对于教育普通民众预防、筛查、诊断和治疗这些疾病至关重要;他们还讨论了使用优质防晒产品控制这些疾病的重要性。

  • 2022 年 5 月 25 日,贝拉·奥罗拉 (Bella Aurora) 庆祝国际皮肤色素沉着日。凭借 130 多年的皮肤色素沉着研究经验,贝拉·奥罗拉在美国、西班牙、意大利和墨西哥的知名皮肤科医生、药剂师和关键意见领袖的支持下发起了一项国际宣传活动来庆祝这一天。
  • 2021 年 6 月,Dermalogica Clear 发起了一项活动,旨在鼓励人们接受皮肤,并教育受众了解炎症后色素沉着、痤疮、痘痘等。
  • 印度 Zydus Healthcare 于 2023 年 4 月 1 日至 5 月 31 日开展了全国性黄褐斑宣传运动,也称为“面向世界”活动,以提高人们对黄褐斑的认识。2023 年 8 月,Zydus Healthcare 创下了参与该活动的最大医疗保健专业人员 (HCP) 记录,共有 18,737 名 HCP 参与了该活动,他们为让大量患者了解黄褐斑做出了贡献。

人们对黄褐斑和其他色素沉着症的认识不断提高,导致对创新有效的治疗产品和程序的需求激增。此外,它还为社会理解和管理色素沉着带来了重大而积极的变化。因此,越来越多的宣传计划促进了色素沉着症治疗市场的增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

色素沉着症治疗市场:

色素沉着症治疗市场
  • Hyperpigmentation Disorder Treatment Market
    复合年增长率(2022 - 2030 年)
    7.4%
  • 2022 年市场规模
    66.8 亿美元
  • 2030 年市场规模
    117.8 亿美元

市场动态

增长动力
  • 黄褐斑患病率上升
  • 色素沉着障碍认知计划数量不断增加
未来的趋势
  • 烧蚀激光的使用
  • 基于 PATH-3 技术的新产品
机会
  • 市场参与者的战略举措

关键人物;主力;重要一员

  • 艾伯维公司(AbbVie Inc.)
  • 拜耳公司,
  • Epipharm AG,
  • 高德美实验室,
  • Obagi 药妆品有限公司,
  • 陆创尼公司
  • 拉普里斯汀,
  • 欧莱雅集团
  • 皮尔法伯集团,
  • Vivier Pharma 美国

区域概况

Hyperpigmentation Disorder Treatment Market
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 以及南美洲和中美洲

市场细分

Hyperpigmentation Disorder Treatment Market治疗类型
  • 药妆
  • 光疗或激光疗法
  • 微晶磨皮
  • 化学换肤
  • 冷冻疗法
  • 其他的
Hyperpigmentation Disorder Treatment Market健康)状况
  • 黄褐斑
  • 日光性雀斑
  • 炎症后色素沉着
  • 其他的
Hyperpigmentation Disorder Treatment Market最终用户
  • 医院
  • 皮肤科中心
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

限制:

 

治疗费用高昂

成本是选择性手术或治疗的一个重要因素。药妆、化学换肤、冷冻疗法、光疗或激光疗法、微晶磨皮和其他色素沉着治疗的成本取决于所采用技术的类型、过程或疗法所需的时间和精力、设施的地理位置以及执行治疗的外科医生的专业知识。此外,健康保险不涵盖色素沉着治疗。色素沉着治疗成本非常高。例如,评级最高的活性成分水杨酸每盎司售价近 15.00 美元。此外,曲酸是所有活性成分中成本最高的,即每盎司 24.89 美元,远高于防晒产品的成本(每盎司中位数 3.32 美元)。使用防晒霜是推荐的一线色素沉着治疗方法。

根据美国整形外科医师协会提供的定价详情,几种流行的色素沉着治疗的平均费用如下:

  • 微晶磨皮:2,000 美元
  • 皮肤重塑手术:1,489 美元
  • 微针疗法:300-1,200 美元
  • 磨皮/换肤:1,250-4,500 美元(视地点而定)
  • 去皮:125-350 美元
  • 激光治疗:250 美元或以上
  • 化学换肤疗程:519 美元

上述费用不包括手术室费用或麻醉费用。此外,保险很少涵盖皮肤剥脱、皮肤重修和激光治疗等美容手术。因此,色素沉着治疗的高成本限制了色素沉着症治疗市场的增长。

 

趋势:

 

烧蚀激光的使用

用于治疗色素沉着的激光设备已经取得了许多进展。烧蚀激光器,例如铒:YAG (Er:YAG) 和二氧化碳 (CO2) 已被用于治疗痤疮疤痕。然而,副作用导致这种技术的普及度下降。随后,非烧蚀激光器,例如 NdYAG 激光器和铒玻璃,在色素沉着治疗中获得了关注。虽然这种技术风险较小,但由于效果不佳,因此并不可靠。随着分数技术的进步,使用 CO2 和铒 YAG 等烧蚀激光器治疗色素沉着已重新流行起来。因此,预计在预测期内,使用 CO2 和 Er:YAG 等烧蚀激光器将带来新的色素沉着障碍治疗市场趋势。

 

报告细分和范围:

色素沉着症治疗市场分析是通过考虑以下几个部分进行的:治疗类型、病情和最终用户。

根据治疗类型,市场细分为药妆、光疗或激光疗法、微晶换肤术、化学换肤、冷冻疗法等。2022 年,药妆领域占据了色素沉着障碍治疗市场的最大份额。药妆兼具美容和药用功能,在护肤领域获得了极大关注,尤其是在解决色素沉着等问题方面。强效活性药物成分与化妆品配方相结合,可有效针对特定的皮肤问题。对于色素沉着的治疗,药妆的效果超越了传统的护肤产品,可以淡化黑斑、均匀肤色和增强皮肤光泽。维生素 C、烟酰胺、曲酸和 α 羟基酸等成分通常存在于专为色素沉着而设计的药妆配方中,具有提亮和调节色素的特性。将先进的药物成分与药妆配方相结合,可提供有针对性的治疗方法,帮助解决与黑色素生成、皮肤变色和色素沉着不均匀相关的问题,从而促进肤色更加均衡和有光泽。此外,微晶磨皮细分市场预计将在预测期内实现最高的复合年增长率。

根据病症,市场分为黄褐斑、日光性雀斑、炎症后色素沉着和其他。黄褐斑领域在 2022 年占据了色素沉着障碍治疗市场的最大份额。预计在预测期内,该领域将录得最高的复合年增长率。

根据最终用户,市场分为医院、皮肤​​病中心和其他。医院部分在 2022 年占据了最大的市场份额。此外,预计皮肤病中心部分在预测期内的复合年增长率最高。

 

区域分析:

从地域上看,色素沉着症治疗市场报告的范围包括北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据了最大的市场份额。提供色素沉着症治疗服务的诊所和医院数量不断增加,产品获批和上市数量不断增加,推动了加拿大色素沉着症治疗市场的增长。例如,2023 年 3 月,加拿大医疗器械公司 Candela 的皮秒激光系统获得了加拿大卫生部的批准,该系统此前已获准用于良性色素病变治疗、纹身去除、痤疮疤痕治疗和皱纹减少手术等。这些因素共同促进了北美色素沉着症治疗市场规模的扩大。

 

色素沉着症治疗市场报告范围

报告属性细节
2022 年市场规模66.8亿美元
2030 年的市场规模117.8亿美元
全球复合年增长率(2022 - 2030 年)7.4%
历史数据2021-2022
预测期2024-2031
涵盖的领域按治疗类型
  • 药妆
  • 光疗或激光疗法
  • 微晶磨皮
  • 化学换肤
  • 冷冻疗法
  • 其他的
按条件
  • 黄褐斑
  • 日光性雀斑
  • 炎症后色素沉着
  • 其他的
按最终用户
  • 医院
  • 皮肤科中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 法国
  • 德国
  • 英国
  • 西班牙
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太其他地区
中东和非洲
  • 沙特阿拉伯
  • 阿联酋
  • 南非
  • 中东和非洲其他地区
以及南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
市场领导者和主要公司简介
  • 艾伯维公司(AbbVie Inc.)
  • 拜耳公司,
  • Epipharm AG,
  • 高德美实验室,
  • Obagi 药妆品有限公司,
  • 陆创尼公司
  • 拉普里斯汀,
  • 欧莱雅集团
  • 皮尔法伯集团,
  • Vivier Pharma 美国
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

行业发展和未来机遇:

根据公司新闻稿,色素沉着症治疗市场主要参与者的一些战略发展如下:

  • 2024 年 2 月,巴黎欧莱雅推出了乙醇酸亮白黑眼圈眼部精华液,这是一款突破性的眼部色素沉着和浮肿解决方案。这款精华液由 3% 的乙醇酸、维生素 CG 和烟酰胺混合而成,承诺在短短 2 周内减少 49% 的黑眼圈。这款精华液经过眼科测试,适合所有皮肤类型,并经临床证明可治疗明显的黑眼圈。
  • 2023 年 10 月,Galderma 在加拿大和英国两个重要市场扩展了其护肤品牌 Alastin。Galderma 宣布计划在加拿大直接分销 Alastin,并在英国推出该品牌。Galderma 在这两个市场的美学业务扩张将提高 Alastin 的知名度,并有助于推动医疗保健专业人士和消费者采用它。
  • 2023 年 1 月,AbbVie 公司的子公司 Allergan Aesthetics 推出了 SkinMedica Even & Correct Collection。该产品系列由三款产品组成:高级亮白护理霜、暗斑霜和亮白护理垫,旨在提供有针对性的效果,并协同作用均匀肤色,减少面部色素沉着和暗斑的出现。

 

竞争格局和重点公司:

AbbVie Inc、Bayer AG、Epipharm AG、Galderma Laboratories、Obagi Cosmeceuticals LLC、Lutronic Corporation、La Pristine、L'oreal SA、Pierre Fabre Group 和 Vivier Pharma USA 是色素沉着症治疗市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球日益增长的消费者需求。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What factors drive the hyperpigmentation disorder treatment market?

Factors such as simplified and minimally invasive procedures, and wide range of applications; and improvements in comfort, efficiency, and outcomes with technological advancements propel the hyperpigmentation disorder treatment market. However, the potential side effects and regulatory challenges hamper the growth of the market.

What is hyperpigmentation disorder treatment?

Hyperpigmentation is a common dermatologic condition referring to skin darkening due to excessive melanin production in the epidermis or dermis layer. It is not harmful but can be perceived as a significant cosmetic flaw and becomes a persistent psychological burden for the patient if not addressed in time. Factors such as rise in prevalence of melasma and increasing number of hyperpigmentation disorder awareness programs propel the market growth. However, high cost of treatments impedes the growth of the market.

Which condition segment dominates the hyperpigmentation disorder treatment market?

The market, by condition, is categorized into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest hyperpigmentation disorder treatment market share in 2022. It is further anticipated to register the highest CAGR during the forecast period.

Which end user segment dominates the hyperpigmentation disorder treatment market?

The market, by end user, is categorized into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022, Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.

What was the estimated hyperpigmentation disorder treatment market size in 2022?

The hyperpigmentation disorder treatment market was valued at US$ 6,676.23 million in 2022.

Who are the major players in the hyperpigmentation disorder treatment market?

The hyperpigmentation disorder treatment market majorly consists of the players, including AbbVie Inc, Bayer AG, Epipharm AG, Galderma Laboratories, Obagi Cosmeceuticals LLC, Lutronic Corporation, La Pristine, L’oreal S.A, Pierre Fabre Group, and Vivier Pharma USA.

What are the growth estimates for the hyperpigmentation disorder treatment market till 2030?

The hyperpigmentation disorder treatment market is expected to be valued at US$ 11,788.50 million in 2030.

Which treatment type segment dominates the hyperpigmentation disorder treatment market?

By treatment type, the market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest hyperpigmentation disorder treatment market share in 2022. Further, the microdermabrasion segment is anticipated to register the highest CAGR during the forecast period.

The List of Companies - Hyperpigmentation Disorder Treatment Market

  1. Abbvie Inc.
  2. Bayer AG
  3. Epipharm AG
  4. Galderma Laboratories
  5. Obagi Cosmeceuticals LLC
  6. Lutronic Corporation
  7. La Pristine
  8. L’oreal S.A
  9. Pierre Fabre Group
  10. Vivier Pharma USA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..